Literature DB >> 25961777

Engineering haploidentical transplants.

S Naik1, H E Heslop1.   

Abstract

Mesh：

Year:  2015        PMID： 25961777     DOI： 10.1038/bmt.2015.115

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  28 in total

1.  Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.

Authors:  D Teschner; E Distler; D Wehler; M Frey; D Marandiuc; K Langeveld; M Theobald; S Thomas; W Herr
Journal:  Bone Marrow Transplant       Date:  2013-08-12       Impact factor: 5.483

Review 2.  Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies.

Authors:  Mary Eapen; Paul O'Donnell; Claudio G Brunstein; Juan Wu; Kate Barowski; Adam Mendizabal; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-23       Impact factor: 5.742

Review 3.  Immune reconstitution after haploidentical hematopoietic stem cell transplantation.

Authors:  Ying-Jun Chang; Xiao-Yu Zhao; Xiao-Jun Huang
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-04       Impact factor: 5.742

Review 4.  Graft-versus-host disease.

Authors:  Warren D Shlomchik
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

5.  Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.

Authors:  Marie Bleakley; Shelly Heimfeld; Lori A Jones; Cameron Turtle; Diane Krause; Stanley R Riddell; Warren Shlomchik
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-11       Impact factor: 5.742

6.  T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.

Authors:  Asad Bashey; Xu Zhang; Connie A Sizemore; Karen Manion; Stacey Brown; H Kent Holland; Lawrence E Morris; Scott R Solomon
Journal:  J Clin Oncol       Date:  2013-02-19       Impact factor: 44.544

7.  Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study.

Authors:  S R Yoon; Y S Lee; S H Yang; K H Ahn; Je-H Lee; Ju-H Lee; D Y Kim; Y A Kang; M Jeon; M Seol; S G Ryu; J W Chung; I Choi; K H Lee
Journal:  Bone Marrow Transplant       Date:  2009-11-02       Impact factor: 5.483

8.  Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.

Authors:  Hong Zheng; Catherine Matte-Martone; Hongmei Li; Britt E Anderson; Srividhya Venketesan; Hung Sheng Tan; Dhanpat Jain; Jennifer McNiff; Warren D Shlomchik
Journal:  Blood       Date:  2007-11-28       Impact factor: 22.113

Review 9.  Advances in graft-versus-host disease biology and therapy.

Authors:  Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Nat Rev Immunol       Date:  2012-05-11       Impact factor: 53.106

10.  Inducible apoptosis as a safety switch for adoptive cell therapy.

Authors:  Antonio Di Stasi; Siok-Keen Tey; Gianpietro Dotti; Yuriko Fujita; Alana Kennedy-Nasser; Caridad Martinez; Karin Straathof; Enli Liu; April G Durett; Bambi Grilley; Hao Liu; Conrad R Cruz; Barbara Savoldo; Adrian P Gee; John Schindler; Robert A Krance; Helen E Heslop; David M Spencer; Cliona M Rooney; Malcolm K Brenner
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.